前列腺癌患者根治性前列腺切除术后辅助放疗与挽救性放疗
本文系统综述了2009年1月至2016年8月Medline和EMBASE数据库文献,分析根治性前列腺切除术后放疗的作用。三项随机试验显示术后立即放疗降低侵袭性前列腺癌复发风险,但增加急性和晚期副作用;回顾性研究支持观察后挽救性放疗的肿瘤学疗效,但延迟对长期控制的影响尚不确定。
要点
- 三项随机试验显示根治性前列腺切除术后立即放疗降低侵袭性前列腺癌患者的复发风险。
- 术后立即放疗与急性和晚期副作用风险增加相关,分别为15%至35%和2%至8%。
- 回顾性研究支持观察后首次复发迹象时行挽救性放疗的肿瘤学疗效,但延迟对长期控制的影响尚不确定。
核心结论
- 根治性前列腺切除术后立即放疗降低侵袭性疾病患者的复发风险,但与短期和长期副作用发生率增加相关。
- 观察后首次复发迹象时行挽救性放疗可能与持久癌症控制相关,但尚待与辅助放疗进行前瞻性随机比较。
- 剂量递增、技术改进和同期激素治疗可能改善术后放疗患者的结局。
研究设计与样本
- 系统文献综述,检索Medline和EMBASE数据库,检索词包括根治性前列腺切除术、辅助放疗和挽救性放疗,单独或组合使用,检索限制为2009年1月至2016年8月发表的研究。
主要发现
- 三项随机试验显示根治性前列腺切除术后立即放疗降低侵袭性前列腺癌患者的复发风险。
- 术后立即放疗与急性和晚期副作用风险增加相关,急性副作用范围为15%至35%,晚期副作用范围为2%至8%。
- 回顾性研究支持初始观察后首次复发迹象时行挽救性放疗的肿瘤学疗效,但延迟对长期控制的影响仍不确定。
临床怎么用
- 基于临床特征和分子谱的准确患者选择至关重要。
- 剂量递增、全盆腔放疗、新技术和激素治疗的使用可能改善术后放疗的结局。
局限性
- 延迟对长期控制的影响仍不确定。
- 尚待与辅助放疗进行前瞻性随机比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Prostate cancer (PCa) patients found to have adverse pathologic features following radical prostatectomy (RP) are less likely to be cured with surgery alone. OBJECTIVE: To analyze the role of postoperative radiotherapy (RT) in patients with aggressive PCa. EVIDENCE ACQUISITION: We performed a systematic literature review of the Medline and EMBASE databases. The search strategy included the terms radical prostatectomy, adjuvant radiotherapy, and salvage radiotherapy, alone or in combination. We limited our search to studies published between January 2009 and August 2016. EVIDENCE SYNTHESIS: Three randomized trials demonstrated that immediate RT after RP reduces the risk of recurrence in patients with aggressive PCa. However, immediate postoperative RT is associated with an increased risk of acute and late side effects ranging from 15% to 35% and 2% to 8%, respectively. Retrospective studies support the oncologic efficacy of initial observation followed by salvage RT administered at the first sign of recurrence; however, the impact of this delay on long-term control remains uncertain. Hopefully, ongoing randomized trials will shed light on the role of adjuvant RT versus observation±salvage RT in individuals with adverse features at RP. Accurate patient selection based on clinical characteristics and molecular profile is crucial. Dose escalation, whole-pelvis RT, novel techniques, and the use of hormonal therapy might improve the outcomes of postoperative RT. CONCLUSIONS: Immediate RT reduces the risk of recurrence after RP in patients with aggressive disease. However, this approach is associated with an increase in the incidence of short- and long-term side effects. Observation followed by salvage RT administered at the first sign of recurrence might be associated with durable cancer control, but prospective randomized comparison with adjuvant RT is still awaited. Dose escalation, refinements in the technique, and the concomitant use of hormonal therapies might improve outcomes of patients undergoing postoperative RT. PATIENT SUMMARY: Postoperative radiotherapy has an impact on oncologic outcomes in patients with aggressive disease characteristics. Salvage radiotherapy administered at the first sign of recurrence might be associated with durable cancer control in selected patients but might compromise cure in others.
引用
- Gandaglia G, Briganti A, Clarke N, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. 2017. PMID: 28189428. doi:10.1016/j.eururo.2017.01.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。